Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Weak
Garp
Neutral
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Weak
Earnings
Strong
Dividends
Very Weak
Capital Efficiency
Strong
Balance Sheet
Very Weak
Website
Fennec Pharmaceuticals Inc.
Telephone
1.919.636.4530
Address
68 T.W. Alexander Drive, Research Triangle Park, Durham, NC 27709
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 5.65 - 10.27
Trade Value (12mth)
US$268,588.00
1 week
0%
1 month
45.96%
YTD
26.95%
1 year
22.33%
All time high
124.20
EPS 3 yr Growth
-62.20%
EBITDA Margin
-14.10%
Operating Cashflow
-$14m
Free Cash Flow Return
-60.50%
ROIC
-40.90%
Interest Coverage
-2.90
Quick Ratio
6.20
Shares Outstanding (Fully Diluted)
36m
HALO Sector
Healthcare
Next Company Report Date
30-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 19 May 26 | |
| 19 May 26 | |
| 15 May 26 | |
| 15 May 26 | |
| 15 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.6 | -0.02 | -0.34 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.6 | -0.02 | -0.34 | | | | ||
Growth | % | | | | | 33.1 | 97.4 | -2,030.6 | | | | ||
PE | X | | | | | N/A | 27 | 214.2 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
